Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#131 / 167 Total
ATRC - Atricure Inc - Stock Price Chart
TickerATRC [NASD, RUT]
CompanyAtricure Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap1.01BEPS (ttm)-0.80
P/E-EPS this Y-17.88%
Forward P/E-EPS next Y19.76%
PEG-EPS past 5Y-1.17%
P/S2.44EPS next 5Y20.00%
P/B2.21EPS Q/Q-102.14%
Dividend-Sales Q/Q16.43%
Insider Own3.17%Inst Own98.67%
Insider Trans-0.94%Inst Trans-1.47%
Short Float6.83%EarningsMay 01/a
Analyst Recom1.00Target Price47.33
Avg Volume783.10K52W Range20.19 - 59.61
AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Noznesky Justin JChief Mktg & Strategy OfficerMay 01 '24Sale24.091,50036,13571,284May 03 08:51 AM
Noznesky Justin JChief Mktg & Strategy OfficerApr 01 '24Sale30.391,50045,58572,784Apr 03 08:41 AM
Dahlquist Karl S.Chief Legal OfficerMar 18 '24Sale32.161,88560,62250,954Mar 20 08:41 AM
Noznesky Justin JChief Mktg & Strategy OfficerMar 12 '24Sale36.721,50055,08074,284Mar 14 08:55 AM
Dahlquist Karl S.Chief Legal OfficerMar 05 '24Sale37.368,231307,51052,839Mar 07 07:28 AM
SRDX - Surmodics, Inc. - Stock Price Chart
TickerSRDX [NASD, RUT]
CompanySurmodics, Inc.
CountryUSA
IndustryMedical Devices
Market Cap463.31MEPS (ttm)0.96
P/E33.96EPS this Y-479.69%
Forward P/E-EPS next Y97.94%
PEG3.40EPS past 5Y20.22%
P/S3.24EPS next 5Y10.00%
P/B3.74EPS Q/Q103.16%
Dividend-Sales Q/Q17.50%
Insider Own4.24%Inst Own91.73%
Insider Trans0.00%Inst Trans0.25%
Short Float3.46%EarningsMay 01/b
Analyst Recom1.00Target Price58.25
Avg Volume72.19K52W Range16.79 - 39.41
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BEDOYA JOSE HDirectorFeb 08 '24Option Exercise23.953,93294,17130,108Feb 12 04:18 PM
KNIGHT SUSAN EDirectorFeb 05 '24Option Exercise23.953,93294,17136,267Feb 07 04:27 PM
DANTZKER DAVIDDirectorJan 19 '24Option Exercise23.953,93294,17140,094Jan 23 05:46 PM
KALICH RONALD B SRDirectorDec 27 '23Option Exercise23.953,93294,17138,529Dec 29 04:26 PM
Stich Joseph J.SVP HR and IVDNov 15 '23Option Exercise23.9517,121410,04872,433Nov 17 04:07 PM
OUT - Outfront Media Inc - Stock Price Chart
TickerOUT [NYSE, RUT]
CompanyOutfront Media Inc
CountryUSA
IndustryREIT - Specialty
Market Cap2.50BEPS (ttm)-2.67
P/E-EPS this Y125.34%
Forward P/E19.18EPS next Y16.73%
PEG-EPS past 5Y-
P/S1.37EPS next 5Y10.00%
P/B4.78EPS Q/Q5.98%
Dividend10.57%Sales Q/Q3.21%
Insider Own20.63%Inst Own87.94%
Insider Trans0.00%Inst Trans9.97%
Short Float4.43%EarningsMay 02/a
Analyst Recom2.00Target Price17.00
Avg Volume2.02M52W Range8.18 - 17.02
OUTFRONT Media, Inc. leases advertising space on out-of-home advertising structures and sites. Its inventory consists of billboard displays, which are primarily located on the most heavily traveled highways & roadways, and transit advertising displays operated under exclusive multi-year contracts with municipalities in large cities across the U.S. and Canada. It operates through the U.S. Media and other segments. The U.S. Media segment includes U.S. Billboard and Transit. The company was founded in 1938 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Senese JodiEVP & Chief Marketing OfficerFeb 20 '24Option Exercise0.0028,6020145,100Feb 22 06:27 PM
MARTIN PATRICKSVP, Controller, CAOFeb 20 '24Option Exercise0.006,512026,846Feb 22 06:26 PM
Sauer Richard H.EVP, General CounselFeb 20 '24Option Exercise0.0035,4040116,247Feb 22 06:25 PM
Male Jeremy J.Chairman & CEOFeb 20 '24Option Exercise0.00172,6770795,261Feb 22 06:34 PM
Punter Clive A.EVP and Chief Revenue OfficerFeb 20 '24Option Exercise0.0056,3370230,984Feb 22 06:31 PM
TD - Toronto Dominion Bank - Stock Price Chart
TickerTD [NYSE]
CompanyToronto Dominion Bank
CountryCanada
IndustryBanks - Diversified
Market Cap96.86BEPS (ttm)4.69
P/E11.67EPS this Y-3.29%
Forward P/E8.96EPS next Y7.09%
PEG2.85EPS past 5Y-2.32%
P/S1.21EPS next 5Y4.10%
P/B1.27EPS Q/Q87.57%
Dividend5.50%Sales Q/Q24.41%
Insider Own0.17%Inst Own55.10%
Insider Trans0.00%Inst Trans0.13%
Short Float1.47%EarningsMay 23/b
Analyst Recom2.75Target Price63.70
Avg Volume2.96M52W Range54.69 - 66.15
The Toronto-Dominion Bank engages in the provision of financial products and services. It operates through the following segments: Canadian Personal and Commercial Banking, U.S. Retail, Wealth Management and Insurance, Wholesale Banking, Corporate segment. The Canadian Personal and Commercial Banking segment is involved in the provision of deposit, saving, payment, and lending products and advice. It also offers customized products and services to help business owners meet financing, investment, cash management, international trade, and day-to-day banking needs through its network of commercial branches and specialized customer centers. The U.S. Retail segment focuses on personal, business banking, and wealth management operations in the U.S. The Wealth Management and Insurance segment offers wealth and asset management products and advice to retail clients in Canada through the direct investing, advice-based, and asset management businesses. The Wholesale Banking segment serves corporate, government, and institutional clients in key financial markets around the world. The Corporate segment consists of service and control groups, including technology solutions, shared services, treasury and balance sheet management, marketing, human resources, finance, risk management, compliance, anti-money laundering, legal, real estate, and others. The company was founded on February 1, 1955 and is headquartered in Toronto, Canada.
NNVC - NanoViricides Inc - Stock Price Chart
TickerNNVC [AMEX]
CompanyNanoViricides Inc
CountryUSA
IndustryBiotechnology
Market Cap13.31MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.25%
P/S-EPS next 5Y-
P/B1.07EPS Q/Q-19.83%
Dividend-Sales Q/Q-
Insider Own4.62%Inst Own10.28%
Insider Trans0.00%Inst Trans19.17%
Short Float1.00%EarningsFeb 16/a
Analyst Recom1.00Target Price6.50
Avg Volume29.36K52W Range1.00 - 2.00
Apr-30-24 06:30AM NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon (ACCESSWIRE) +6.19%
Feb-15-24 06:30AM NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon (ACCESSWIRE)
Feb-14-24 05:11PM NanoViricides: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Feb-01-24 06:20AM Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics (ACCESSWIRE)
Jan-29-24 06:30AM Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found (ACCESSWIRE) +9.35%
Jan-04-24 06:30AM NanoViricides to Present at the Biotech Showcase in San Fransisco (ACCESSWIRE) +5.83%
Nov-29-23 01:32PM NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387 (News Direct)
Nov-28-23 06:40AM The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Companys Broad-Spectrum Antiviral Drug, Has Successfully Completed the First Part (Phase 1a), Reports NanoViricides (ACCESSWIRE) +13.73%
Nov-15-23 06:45AM NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications (ACCESSWIRE) -9.70%
05:04AM NanoViricides: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
AMIX - Autonomix Medical Inc. - Stock Price Chart
TickerAMIX [NASD]
CompanyAutonomix Medical Inc.
CountryUSA
IndustryMedical Devices
Market Cap57.69MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own56.40%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.58%Earnings-
Analyst Recom-Target Price-
Avg Volume53.97K52W Range2.50 - 7.60
Autonomix Medical, Inc. is a development stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies. The company was founded by Robert Schwartz, Landy Toth, David A. Robins, and Robert A. Van Tassel on July 10, 2014 and is headquartered in Doylestown, PA.
ISSC - Innovative Solutions And Support Inc - Stock Price Chart
TickerISSC [NASD]
CompanyInnovative Solutions And Support Inc
CountryUSA
IndustryAerospace & Defense
Market Cap109.12MEPS (ttm)0.37
P/E17.09EPS this Y14.29%
Forward P/E10.25EPS next Y52.50%
PEG0.85EPS past 5Y-
P/S2.90EPS next 5Y20.00%
P/B2.73EPS Q/Q50.12%
Dividend-Sales Q/Q42.84%
Insider Own39.17%Inst Own28.89%
Insider Trans0.07%Inst Trans-7.42%
Short Float0.19%EarningsMay 13/b
Analyst Recom1.00Target Price9.40
Avg Volume47.29K52W Range6.29 - 9.00
Innovative Solutions & Support, Inc. engages in the manufacture of flight navigation systems. It designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. It supplies integrated flight management systems, flat panel display systems, integrated standby units, and global positioning system receivers. The company was founded by Geoffrey S. M. Hedrick on February 12, 1988 and is headquartered in Exton, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Olver ParizadDirectorApr 13 '24Option Exercise0.006,868011,806Apr 16 05:53 PM
Belland Stephen LDirectorApr 13 '24Option Exercise0.006,868012,161Apr 16 05:55 PM
Carolin Roger AnthonyDirectorApr 13 '24Option Exercise0.006,868052,790Apr 16 05:56 PM
BRESSNER GLEN RDirectorApr 13 '24Option Exercise0.006,868091,957Apr 16 09:46 PM
BRESSNER GLEN RDirectorSep 08 '23Buy7.8510,00078,46781,393Sep 11 03:39 PM
FDP - Fresh Del Monte Produce Inc - Stock Price Chart
TickerFDP [NYSE, RUT]
CompanyFresh Del Monte Produce Inc
CountryUSA
IndustryFarm Products
Market Cap1.17BEPS (ttm)-0.51
P/E-EPS this Y4.95%
Forward P/E9.39EPS next Y17.30%
PEG-EPS past 5Y12.01%
P/S0.27EPS next 5Y24.00%
P/B0.61EPS Q/Q-32.73%
Dividend3.47%Sales Q/Q-1.84%
Insider Own22.09%Inst Own65.74%
Insider Trans0.02%Inst Trans-0.49%
Short Float0.52%EarningsMay 02/a
Analyst Recom1.00Target Price31.50
Avg Volume210.91K52W Range21.41 - 28.61
Fresh Del Monte Produce, Inc. engages in production and distribution of fresh fruit and vegetable products. It operates through the following segments: Fresh and Value-added products, Bananas, and Other Products and Services. The Fresh and Value-added products segment includes sales of pineapples, melons, non-tropical fruit (including grapes, apples, citrus, blueberries, strawberries, pears, peaches, plums, nectarines, cherries, and kiwis), other fruit and vegetables, avocados, fresh-cut fruit and vegetables, prepared fruit and vegetables, juices, other beverages, and prepared meals and snacks. The Bananas segment produces bananas. The Other Products and Services segment operates the third-party freight and logistics services business and the Jordanian poultry and meats business. The company was founded in 1886 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
APPARECIDO ALEXANDREVP, Global Internal AuditMar 30 '24Option Exercise0.001,08302,964Apr 02 07:06 PM
APPARECIDO ALEXANDREVP, Global Internal AuditMar 30 '24Sale25.913258,4212,639Apr 02 07:06 PM
Calvo Jesus RodriguezSVP, NA Sales & MarketingMar 14 '24Sale24.592,40259,0650Mar 18 06:32 PM
BETTI TAREK AHMADChief Human Resources OfficerMar 14 '24Sale24.421,00024,4202,109Mar 18 06:32 PM
Abbas MohammedChief Operating OfficerMar 05 '24Sale24.353,22278,45629,945Mar 07 06:23 PM
HUBC - Hub Cyber Security Ltd - Stock Price Chart
TickerHUBC [NASD]
CompanyHub Cyber Security Ltd
CountryIsrael
IndustrySoftware - Infrastructure
Market Cap122.27MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-181.36%
Dividend-Sales Q/Q9.73%
Insider Own30.06%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float2.66%Earnings-
Analyst Recom-Target Price-
Avg Volume5.19M52W Range0.68 - 9.40
Hub Cyber Security (Israel) Ltd. engages in the development of computer software and the establishment of quality and reliability systems. It operates through the following segments: Consulting, Software, Training, and Software Testing and Outsourcing. The Consulting segment provides engineering and management consulting services in the fields of management and establishment of quality and reliability systems, reliability and safety analyzes, improvement works of processes and products, risk analysis and management, writing procedures and analytical reports, certification of organizations and companies according to accepted standards. The Software segment engages in software development for calculating reliability and safety data, for collecting and reporting incidents and faults, as well as databases. The Training segment engages in trainings and certifications in the areas of quality, safety, reliability and as part of training for the IDF, in the fields of command, management, organizational behavior, and preparation for military service. The Software Testing and Outsourcing segment provides solutions and services in the fields of test engineering, formation and characterization of processes, establishment of test groups and laboratories, development of quality indices, implementation of test methodologies in accordance with the organization's strategy and placement of employees in the above fields. The company was founded by Zigmund Bluvband on June 13, 1984 and is headquartered in Tel Aviv, Israel.
VIAV - Viavi Solutions Inc - Stock Price Chart
TickerVIAV [NASD, RUT]
CompanyViavi Solutions Inc
CountryUSA
IndustryCommunication Equipment
Market Cap1.68BEPS (ttm)-0.02
P/E-EPS this Y-40.00%
Forward P/E15.87EPS next Y44.32%
PEG-EPS past 5Y-
P/S1.66EPS next 5Y15.00%
P/B2.39EPS Q/Q-60.55%
Dividend-Sales Q/Q-0.73%
Insider Own1.43%Inst Own96.26%
Insider Trans-1.19%Inst Trans-1.61%
Short Float2.19%EarningsMay 02/a
Analyst Recom2.00Target Price10.33
Avg Volume2.01M52W Range7.26 - 11.65
May-03-24Downgrade Susquehanna Positive → Neutral $9
Viavi Solutions, Inc. engages in the provision of network test, monitoring, and assurance solutions for communications service providers, enterprises, network equipment manufacturers, government and avionics. It operates through the following segments: Network Enablement, Service Enablement, and Optical Security and Performance. The Network Enablement segment offers an integrated portfolio of testing solutions that access the network to perform build-out and maintenance tasks. The Service Enablement segment covers solutions and services primarily for communication service providers, and enterprises that deliver and/or operate broadband and IP networks (fixed and mobile) supporting voice, video, and data services as well as a wide range of applications. The Optical Security and Performance segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture, and sell products targeting anti-counterfeiting, consumer and industrial, government, healthcare, and other markets. The company was founded in 1979 and is headquartered in Chandler, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McNab PaulEVP, Chief Mktg & Stgy OfficerMar 12 '24Sale10.6215,004159,34257,940Mar 13 02:00 PM
Siebert Kevin ChristopherSVP Gen. Counsel & SecretaryMar 11 '24Sale10.7013,967149,44747,097Mar 12 03:05 PM
KHAYKIN OLEGPresident & CEOFeb 14 '24Option Exercise5.951,180,2577,022,5292,329,612Feb 15 11:56 AM
RONDINONE RALPHSVP Global Operations NSEFeb 01 '24Sale9.851,12211,05232,722Feb 01 04:46 PM
McNab PaulEVP, Chief Mktg & Stgy OfficerDec 12 '23Sale8.828,37473,85972,944Dec 14 02:12 PM
191011121314151617